Search News Archives
Follow us on
Conferences | Events

Media Partners

 

Pioneering Scientist Mel Greaves is Knighted after Research to Unveil Cause of Childhood Leukaemia

publication date: Jan 17, 2019
 | 
author/source: The Institute of Cancer Research

Professor Mel GreavesProfessor Mel Greaves has been knighted in the New Year honours list 2019 for his pioneering and hugely influential research into childhood leukaemia.

Professor Greaves, or Sir Mel, as he can now be known, has carried out groundbreaking work to understand the hidden natural history and causes of childhood leukaemia during a 35-year career at The Institute of Cancer Research, London – leading to advances in diagnosis, treatment and potentially prevention.

He has also been a pioneer in identifying that cancers undergo a form of Darwinian evolution that leads to drug resistance – an insight which has opened up an exciting new field of cancer research and treatment.

In 2018, he published a landmark review in Nature Reviews Cancer which pulled together research data from right across his career to propose when, how and why the most common form of childhood leukaemia develops.

He argued that acute lymphoblastic leukaemia is caused through a combination of genetic mutation and lack of exposure to common infections at an early age – and that this means the disease should, in future, be preventable.

Professor Greaves is now raising money for a new research programme, at The Institute of Cancer Research (ICR), designed to test whether childhood leukaemia can indeed be prevented.

Professor Greaves’ knighthood for services to children’s leukaemia research comes after his receipt of the Royal Society’s prestigious Royal Medal in 2017 – following in the footsteps of previous pre-eminent winners including Charles Darwin, Michael Faraday and Francis Crick.

The New Year honours list is announced by the Cabinet Office and consists of a range of honours for people from a wide variety of walks of life.

Professor Sir Mel Greaves, Director of the Centre for Evolution and Cancer at The Institute of Cancer Research, London, said:

“I am honoured, delighted and somewhat bewildered to have received this honour. When I started out in cancer research my aim was only ever to understand what was causing leukaemia in children and how this new knowledge could make their lives better. It has been a wonderful journey over the last 40 years since I first started studying leukaemia, and I feel very privileged to have been able to contribute towards the unpicking of this once mysterious and lethal disease.

“To gain a knighthood was never remotely in my sights, but I am extremely grateful for the honour and hope it can inspire my many young colleagues as they also look to push back the boundaries of cancer research.”

Professor Paul Workman, Chief Executive of The Institute of Cancer Research, London, said:

“Everyone at the ICR is incredibly proud of Mel for this thoroughly well-deserved honour, and more importantly for the lifetime of pioneering cancer research which has earned it.

“Mel’s breakthroughs have helped transform our understanding of how childhood leukaemia develops and how it is treated, and the next stage of his research has the potential to turn it into a preventable disease.

“We also have to thank Mel for inspiring cancer researchers across the world to look at cancer from an evolutionary perspective. This approach has transformed the way we think about cancer, and is inspiring us to create a new generation of anti-evolution treatments with the potential to overcome drug resistance.”


Find out more about Professor Sir Mel Greaves’ research into childhood leukaemia.

 

 

more from the ICR




 


Popular this Month

 

Win a PIPETBOY from the new Integra summer collection!

 

Great Savings off Selected GC Columns

 

CytoSMART raises 5.2 million Euros for further product innovation and growth

 

High Volume Sample Storage in Space Efficient 96-Well Format

 

Cherwell Publishes Guide on Sterility Testing

 

Effective Removal of DMSO from Stored Samples

 

ATL Webcast: A Practical Guide to Selecting the Right LIMS

 

Genetic study reveals how gut bacteria work to keep us healthy

 

Lonza Establishes Custom Cell Biology Services to Offer Unique Manufacturing and Testing Capabilities

 

Thermo Fisher Scientific Opens Food Safety Customer Solution Center in India

 

 


 

 


 

Can't find what you are looking for?

Search by company or by product


Company Name:

Product:


 

 

Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.

Lab Bulletin is published by newleaf marketing communications ltd